COMBINATION ANTI-HER2 CANCER THERAPY USING MUC1 PEPTIDES AND CHEMOTHERAPEUTICS

• 收藏
• 分享

专利权人:

发明人:

Donald W. KUFE,Surender KHARBANDA

申请号：

US14774155

公开号：

US20160074468A1

申请日:

2014.03.10

申请国别(地区):

US

年份:

2016

代理人:

摘要：

The invention provides for treatment of HER2+ cancers using a combination of anti-MUC1 therapy and anti-HER2 therapy. In particular, the invention addresses the treatment of trastuzamab-resistant cancers, both primary and acquired, using the same combination of agents.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/